S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

Ginkgo Bioworks Holdings, Inc.

DNA XNYS
$6.88 -0.15 (-2.18%) ▼ 15-min delayed
Open
N/A
High
N/A
Low
N/A
Volume
N/A
Market Cap
$426.04M

About Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 485 Website →

Key Financials

Period Revenue Net Income EPS
TTM 2025 $170.16M $-312,763,000 $-5.64
FY 2025 $170.16M $-312,763,000 $-5.64
Q3 2025 $38.84M $-80,755,000 $-1.45
Q2 2025 $49.60M $-60,300,000 $-1.10

Related Market News

No specific coverage for DNA yet. Check out our latest market news or earnings calendar.

Get DNA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Ginkgo Bioworks Holdings, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.